Abstract Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis are human fungal pathogens with clinical importance. The recently reclassified three closely related species have significant variation in virulence, clinical prevalence and susceptibility characteristics to different antifungal compounds.
Introduction
Molecular studies of the Candida parapsilosis subtypes recently led to their separation into different, closely related species: the more prevalent C. parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis [1] . Human diseases caused by C. parapsilosis complex have significantly increased in importance and prevalence over the last decade [2, 3] . Recently, survey data from different hospitals [4, 5] show that C. parapsilosis sensu stricto is the second or third most common Candida spp. isolated from blood cultures. The examination of the distribution of the strains within the C. parapsilosis complex from different isolates obtained from blood and other sterile sources in European tertiary-care hospital revealed that the majority of the isolates (111 of 122) were C. parapsilosis sensu stricto, whereas significantly fewer (10 of 122) were identified as C. orthopsilosis and only one isolate was identified as C. metapsilosis [4] . This has been observed in other studies [5] .
The sensitivity of the three species to antifungal drugs is different [4, 5] , indicating that accurate identification would influence therapy. Conventional laboratory methods are unable to differentiate the three species, and although molecular methods are rapid and sensitive, they are not routinely available.
Statins were originally identified as fungal metabolites [6] that act as selective inhibitors of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase [7] , which is the enzyme responsible for the conversion of hydroxy-methylglutaryl-coenzyme A into mevalonic acid. In addition to their cholesterollowering effects, statins possess antifungal activity through inhibiting the formation of ergosterol, which is a key component of the cell membrane [8] [9] [10] . The minimal inhibitory concentrations of current statins against pathogenic fungi and yeasts are rather high; hence, they are not clinically useful as the required dose for a therapeutic effect would be associated with unacceptable serious, toxic side effects. However, statins can potentially serve to differentiate Candida species based on susceptibility profiles.
In the present study, the susceptibility of 13 strains of C. metapsilosis, 20 of C. orthopsilosis and 21 of C. parapsilosis sensu stricto to atorvastatin and fluvastatin was examined.
Materials and Methods

Yeast Strains and Cultivation
Strains used in these experiments are listed in Table 1 . They were maintained on YPD (1 % glucose, 1 % peptone, 0.5 % yeast extract, 2 % agar) medium at 4°C. Clinical isolates originated from Hungarian hospitals were identified by ITS sequencing in a previous work [11] .
Statins
Atorvastatin (Atoris, KRKA) and fluvastatin (Lescol, Novartis) were of pharmaceutical grade. Stock solutions were prepared by dissolving the drugs in methanol and then stored at -80°C. The concentration of the stock solutions was as follows: atorvastatin 20 mg mL -1 , and fluvastatin 40 mg mL -1 .
In Vitro Susceptibility Test
The in vitro antimycotic effect of atorvastatin and fluvastatin was determined by a microdilution method.
The stock solution of statins was diluted in yeast nitrogen base (YNB) without amino acids (DIFCO) liquid medium and applied in final concentrations of 50-1.56 lg mL -1 in the case of atorvastatin and 25-0.78 lg mL -1 in the case of fluvastatin. The experiments were carried out in final volume of 100 lL in 96-well microplates. Yeast nitrogen base medium was prepared as suggested by the supplier and contained 1 % glucose as the carbon source. Yeast cell inoculates were prepared from 2-day-old cultures cultivated in YPD liquid medium at 30°C with vigorous shaking. The cells were washed with sterile distilled water, and after repeated washing, they were suspended in YNB. The initial cell concentration in each well was adjusted to 4 9 10 4 cells mL -1 . The microplate cultures were then grown at 30°C for 48 h with shaking in a BIOTEK SynergyHT shaker. Growth was detected by checking the optical density (OD) of the cultures at 600 nm in every 5 min (Gen5 software). Non-inoculated medium was used as background, and the growth control contained inoculated YNB medium (initial cell concentration was 4 9 10 4 cells mL -1 ). A growth control containing the same amount of methanol as the statin-containing samples was also applied.
The experiments were repeated two times, each plate carried two parallels per each strain and each statin.
Plate Assay
Strains cultivated for 48 h at 30°C in YPD medium were diluted in YNB medium, and 10 5 , 10 4 , 10 3 and 10 2 cells were spotted onto YNB plates containing 30, 40 and 50 lg mL -1 fluvastatin or atorvastatin, respectively. The plates were incubated at 30°C for 5 days.
Results and Discussion
The in vitro minimal inhibitory concentration (MIC) of atorvastatin and fluvastatin against the species of C. parapsilosis sensu lato complex was studied by microdilution method. Three strains of each species were included in the study: C. metapsilosis SZMC 8022, SZMC 1547, SZMC 1548; C. orthopsilosis SZMC 1545, SZMC 8119, SZMC 8121; and C. parapsilosis CBS 6318, SZMC 1577, SZMC 8002. The applied concentration range was between 50 and 1.56 lg mL -1 for atorvastatin ( Fig. 1 ) and 25-0.78 lg mL -1 for fluvastatin (Fig. 2) . The antifungal activity of the atorvastatin varied; C. parapsilosis was the most sensitive species while the susceptibility of C. orthopsilosis and C. metapsilosis was similar (Fig. 1) . The MIC 100 value (100 % growth inhibition) of atorvastatin was 25 lg mL -1 for C. parapsilosis 1a) and 50 lg mL -1 for C. orthopsilosis and C. metapsilosis (Fig. 1b, c) .
Remarkable differences were detected in the sensitivity to fluvastatin: C. parapsilosis was the most susceptible species, while C. orthopsilosis proved the less sensitive to it (Fig. 2) . Fluvastatin was more effective than atorvastatin, as it completely inhibited the growth of C. parapsilosis at 12.5 lg mL -1 concentration (Fig. 2a) . C. orthopsilosis was the least susceptible to fluvastatin (Fig. 2b) as 12.5 lg mL -1 concentration caused only 50 % growth inhibition. In the case of C. metapsilosis, 90 % inhibition was demonstrated at this concentration (Fig. 2c) .
On the basis of the data presented above, we tested the sensitivity of our strains of the three species on solidified YNB medium supplemented with 30, 40 and 50 lg mL -1 fluvastatin or atorvastatin. After 5 days of incubation at 30°C, none of the 21 strains of C. parapsilosis sensu stricto could grow on medium containing the lowest concentration, 30 lg mL -1 , of either fluvastatin or atorvastatin. In contrast, the 20 strains of C. orthopsilosis and the 13 strains of C. metapsilosis formed colonies at 50 lg mL -1 of atorvastatin. At 30 lg mL -1 of fluvastatin, C. orthopsilosis cells grew with inoculates as low as 10 2 cells (Fig. 3b) , whereas C. metapsilosis colonies were detected only at the highest cell densities (Fig. 3c) . Hence, fluvastatin at 30 lg mL -1 concentration was sufficient to discriminate between C. metapsilosis and C. orthopsilosis using different inoculums of these species. Based on these results, fluvastatin was significantly more discriminatory than atorvastatin.
Species differentiation is laborious in the case of closely related human pathogenic fungi or yeasts. Several conventional and molecular methods exist, but all of them have their limits, so new reliable approaches are required. Differences in lovastatin sensitivity have been used for species selection in Rhizomucor genus in a recent study [12] . Based on the remarkable difference observed in the susceptibilities of C. parapsilosis, C. orthopsilosis and C. metapsilosis to fluvastatin, we propose a simple plate assay to distinguish the strains of the three species. Our data indicate that a dilution series of the isolated strain should be inoculated on YNB medium containing 30 lg mL -1 fluvastatin. C. parapsilosis strains should not grow under this condition (Fig. 3a) . As C. orthopsilosis is the most resistant species to this drug, robust growth should occur at each dilution (Fig. 3b) , whereas only the dilutions with 10 4 or 10 5 of C. metapsilosis will have growth (Fig. 3c) . The method was validated with 13 strains of C. metapsilosis, 20 C. orthopsilosis and 21 C. parapsilosis sensu stricto. In conclusion, this method provides a simple and effective method for differentiating these three closely related species, and this approach can be used as an alternative technique for definite identification of C. parapsilosis sensu lato isolates, which will be a useful tool for future epidemiological studies. 
